Search results
Cardinal Health lifts 2024 profit view on demand for costly specialty drugs
Reuters via AOL· 8 hours agoDrug distributors, including rival Cencora, have been benefiting from growing sales of specialty medicines at a time when prices of generic, or copycat, ...
These Are the Drugs America Is Running Short On
247wallst.com· 3 days agoDrug shortages in America are the result of supply line challenges, profit-based operations, and company closures.
Generic Drug Giant Teva Hires New Legal Chief After DOJ Deal
Bloomberg Law· 2 days agoTeva Pharmaceutical Industries Ltd. has a new chief legal officer in David McAvoy, who succeeds David Stark as the top lawyer for the world’s largest generic drug manufacturer.
Cencora beats profit estimates on strong demand for costly specialty drugs
Reuters via AOL· 1 day agoThe drug distributor has been benefiting from specialty drugs and biosimilars - close copies of complex biotech drugs - at a time when intense competition pulls down prices ...
White House Aims to Reclassify Marijuana as Less Dangerous Drug - What’s News - WSJ Podcasts
The Wall Street Journal· 2 days agoAnnmarie Fertoli: The Biden administration wants to reclassify marijuana as a less dangerous drug....
Earnings call: Corcept Therapeutics raises 2024 revenue guidance By Investing.com
Investing.com· 11 hours agoThe company has also raised its revenue guidance for the full year to between $620 million and $650...
FTC Targets ‘Junk’ Patent Listings on Ozempic and Other Drugs
The Wall Street Journal· 2 days agoSome observers have said it is unclear...s scrutiny of the Orange Book will be enough to boost ...
Boehringer Ingelheim Accused of Using Expired Patents to Control Market | Connecticut Law Tribune
Law.com· 2 days agoThe lawsuit, filed Monday in Connecticut federal court, was followed ... Ingelheim, disputing the...
Mark Cuban has a simple question for CVS’s drug middleman: Why don’t you publish your prices?
Ohio Capital Journal via Yahoo News· 6 days agoBusinessman and TV personality Mark Cuban has a seemingly straightforward question for the huge drug...
As UnitedHealth grows richer and more powerful, patients get left behind
The Bergen Record via Yahoo Finance· 2 days agoIn other words, PBMs and insurers collude to pocket the discounts they extract from drug companies, while charging patients coinsurance based on the much higher undiscounted ...